Pietz Jeff, Achanti Babu, Lilien Lawrence, Stepka Erin Clifford, Mehta Sudhir Ken
Neonatal Division, Department of Pediatrics, Fairview Hospital, Cleveland Clinic Health System, Cleveland, Ohio 44111-5656, USA.
Pediatrics. 2007 Jan;119(1):e164-70. doi: 10.1542/peds.2006-0521. Epub 2006 Dec 4.
Diet, indomethacin, and early use of dexamethasone have been implicated as possible causes of necrotizing enterocolitis and intestinal perforation. Because we seldom prescribe indomethacin or early dexamethasone therapy and we follow a special dietary regimen that provides late-onset, slow, continuous drip enteral feeding, we reviewed our 20 years of experience for the incidence of necrotizing enterocolitis and bowel perforation.
We reviewed data on all 1239 very low birth weight infants (501-1500 g) admitted to our level III unit over a period of 20 years (1986-2005), for morphologic parameters, necrotizing enterocolitis, bowel perforation, use of the late-onset, slow, continuous drip protocol, and indomethacin therapy. Outcome data were also compared with Vermont Oxford Network data for the last 4 years.
In 20 years, 1158 infants received the late-onset, slow, continuous drip feeding protocol (group I), whereas 81 infants had either a change in dietary regimen, use of indomethacin, or early use of dexamethasone (group II). The rate of necrotizing enterocolitis in group I of 0.4% was significantly lower than that in group II of 6%. Group I, in comparison with the Vermont Oxford Network, had significantly lower rates of necrotizing enterocolitis (0.4% vs 5.9%), surgical necrotizing enterocolitis (0.4% vs 3.1%), and bowel perforation (0.35% vs 2.2%).
Our 20-year experience with 1239 very low birth weight infants suggests strongly that the late-onset, slow, continuous drip feeding protocol and avoidance of indomethacin and early dexamethasone treatment contribute to the prevention of necrotizing enterocolitis.
饮食、吲哚美辛及早期使用地塞米松被认为可能是坏死性小肠结肠炎和肠穿孔的病因。由于我们很少开具吲哚美辛或早期地塞米松治疗处方,且遵循一种特殊的饮食方案,即采用延迟开始、缓慢、持续滴注的肠内喂养方式,因此我们回顾了20年的经验,以了解坏死性小肠结肠炎和肠穿孔的发生率。
我们回顾了20年(1986 - 2005年)期间入住我院三级病房的所有1239例极低出生体重儿(501 - 1500克)的数据,包括形态学参数、坏死性小肠结肠炎、肠穿孔、延迟开始、缓慢、持续滴注方案的使用情况以及吲哚美辛治疗情况。结局数据还与佛蒙特牛津网络最近4年的数据进行了比较。
20年间,1158例婴儿接受了延迟开始、缓慢、持续滴注喂养方案(第一组),而81例婴儿的饮食方案有改变、使用了吲哚美辛或早期使用了地塞米松(第二组)。第一组坏死性小肠结肠炎的发生率为0.4%,显著低于第二组的6%。与佛蒙特牛津网络相比,第一组坏死性小肠结肠炎(0.4%对5.9%)、外科坏死性小肠结肠炎(0.4%对3.1%)和肠穿孔(0.35%对2.2%)的发生率均显著更低。
我们对1239例极低出生体重儿的20年经验强烈表明,延迟开始、缓慢、持续滴注喂养方案以及避免使用吲哚美辛和早期地塞米松治疗有助于预防坏死性小肠结肠炎。